Fat-storage gene PLIN4 identified as potential anorexia risk factor

Anorexia nervosa has one of the highest mortality rates among psychiatric diseases, affecting approximately 10 times more women than men.
An anorexic gene not in the brain is completely novel
Researcher Michael Lutter on the unexpected discovery that a fat-storage gene, not a brain gene, increases anorexia risk.
Mark

So they found a gene in fat tissue that makes anorexia more likely. That's surprising because we think of eating disorders as psychiatric, right?

Mimi

Exactly. The whole field has assumed anorexia lives in the brain—in distorted thinking, in behavior. This gene, PLIN4, mostly works in fat and muscle. It controls how cells store energy. So it's pointing toward metabolism, not psychology.

Luke

But how many people does this actually affect? The study says 11 percent of their anorexia patients carried these variants, versus 3 percent of healthy controls. That's a real difference, but it's still a minority of patients.

Mimi

Right. This isn't explaining all anorexia. But for the people who do carry these variants, it might be a major piece of why they're susceptible. And it opens up a completely different way to think about treatment.

Mark

The researchers mention this is polygenic—many genes involved. So PLIN4 is one piece of a much larger puzzle?

Mimi

Yes. They're not saying this gene causes anorexia. They're saying it's one of potentially many genetic variants that increase risk. The analogy they use is BRCA genes for breast cancer—rare but powerful.

Luke

I want to flag something: the study looked at 154 patients with "strong family history, multiple courses of unsuccessful treatment or unusual clinical features." That's a very specific, severe population. We don't know yet if PLIN4 matters as much in people with milder or more typical anorexia.

Mimi

That's exactly why they're saying the finding needs replication in a larger, independent population. This is early.

Mark

Why has anorexia been so underfunded compared to other psychiatric disorders?

Mimi

The researchers point to a misperception that it's about vanity—that women just want to be thin. There's probably some misogyny in that, since anorexia affects women ten times more than men. And historically, eating disorders just haven't gotten the research attention they deserve.

Luke

The mortality rate is one of the highest among psychiatric diseases, right? So the underfunding is particularly striking.

Mimi

Exactly. This is a serious, deadly illness. But the treatment options are still basically just nutritional rehabilitation and therapy. No FDA-approved medications. That's why finding genes like PLIN4 matters—it could lead to new drug targets.

Mark

What happens next?

Mimi

The team will look for other genetic variants affecting fat storage and anorexia risk. They'll also study patients' body fat directly to see if there are abnormalities that might explain more about the disease. It's a long road, but it's a new direction.

  • Anorexia carries one of the highest mortality rates of any psychiatric illness, yet it remains among the least funded and least understood conditions in medicine.
  • A study of 154 severe or treatment-resistant patients found that 11% carried rare, function-damaging variants of PLIN4 — a gene tied to fat storage and energy metabolism, not brain chemistry — compared to just 3% of healthy controls.
  • In four families, a close relative with an eating disorder carried the exact same genetic variant as the patient, hinting at a heritable biological pathway hiding in plain sight.
  • The finding directly challenges the entrenched view of anorexia as a purely psychiatric condition, with researchers pointing to gender bias as one reason metabolic explanations were never seriously pursued.
  • No FDA-approved medications exist for anorexia, and the team cautions that replication in larger populations is essential before this discovery can reshape treatment — but if the pathway holds, it could become a map toward entirely new therapies.

For generations, anorexia nervosa has been understood as a disease of the mind — a psychological wound expressed through the body. Researchers at Michigan State University have now found a genetic clue that quietly unsettles that assumption: a fat-storage gene called PLIN4, active in muscle and adipose tissue rather than the brain, appears in rare damaging variants nearly four times more often in anorexia patients than in the general population. The discovery does not overturn what we know, but it opens a door long left unopened — suggesting that for some, the roots of this deadly illness may run through the body's most fundamental metabolic machinery.

Anorexia nervosa kills more reliably than almost any other psychiatric illness, yet for decades the field has treated it as a disorder that lives almost exclusively in the brain — in distorted thinking, in behavior, in psychology. A team at Michigan State University has now found something that doesn't fit that story.

Studying 154 patients with severe or treatment-resistant anorexia, the researchers discovered that 11 percent carried rare, damaging variants of PLIN4, a gene that governs how fat tissue and muscle store energy. In the general population, only about 3 percent carry such variants — making anorexia patients nearly four times as likely to have them. In four families, a close relative with an eating disorder carried the identical genetic change, suggesting the link is heritable and not coincidental.

"The idea of an anorexic gene not in the brain is completely novel," said Michael Lutter, who led the research. His colleague A.J. Robison pointed to a deeper problem: the disease has long been dismissed as vanity or hysteria, partly because it strikes women ten times more often than men. That bias, he argues, has kept metabolic explanations off the table even as evidence of strong genetic heritability — a fivefold to tenfold increased risk among first-degree relatives — has accumulated for years.

Anorexia remains one of the least-funded psychiatric conditions, and treatment has barely evolved beyond nutritional rehabilitation and psychotherapy. There are no FDA-approved medications. Lutter compares his search for anorexia genes to the early hunt for BRCA1 and BRCA2 in breast cancer — rare variants that dramatically elevate risk and, once found, illuminate entire biological pathways that can be targeted therapeutically.

The team is careful: this was a specialized sample, and the findings must be replicated in larger populations before they can be broadly applied. But if PLIN4 proves significant, it redirects the search for answers away from the brain and toward the body's most basic machinery for storing and using energy — a new place to look in a field that has long needed one.

Anorexia nervosa kills more reliably than almost any other psychiatric illness. For decades, researchers have assumed the disease lives in the brain—in the psychology, the behavior, the distorted thinking that drives someone to starve. A team at Michigan State University just found something that doesn't fit that story at all.

They discovered that patients with anorexia were nearly four times as likely as healthy people to carry rare, damaging variants of PLIN4, a gene that has almost nothing to do with the brain. PLIN4 works primarily in fat tissue and muscle, where it controls how cells store energy. The finding, published in Frontiers in Psychiatry, suggests that for some people, anorexia may not be purely a disorder of the mind—it may involve how the body itself handles fat and metabolism.

The research grew from a focused study of 154 patients with particularly severe or treatment-resistant anorexia. Seventeen of them—about 11 percent—carried rare variants of PLIN4 predicted to damage the gene's function. In the general healthy population, only about 3 percent carry such variants. Six anorexia patients had especially disruptive versions, and in four of those families, a close relative with an eating disorder carried the identical genetic change. "The idea of an anorexic gene not in the brain is completely novel," said Michael Lutter, who led the research and now treats eating disorder patients clinically.

The finding challenges what A.J. Robison, an MSU physiology professor who advised the study, calls the prevailing dogma. "The bias is that anorexia is a purely psychiatric disorder or even hysteria in women who just want to be thin," he said. "This new finding flies in the face of the idea that the genes contributing to this disease are expressed in the brain." That bias may run deeper than science. Anorexia strikes women ten times more often than men, and Robison suggests the disease has been dismissed partly because of how people view women and vanity. The evidence tells a different story: someone with a first-degree relative who has anorexia is five to ten times more likely to develop it themselves, suggesting powerful genetic underpinnings.

Yet anorexia remains one of the least studied and least funded psychiatric conditions. A recent analysis of National Institutes of Health funding from 2011 to 2023 found eating disorders among the two lowest-funded categories. Treatment options have barely evolved—patients receive nutritional rehabilitation to restore weight and psychotherapy to address behaviors and thoughts. There are no FDA-approved medications specifically for anorexia. Lutter compares his search for anorexia genes to the hunt for BRCA1 and BRCA2, the breast cancer genes. Those variants are rare but drastically increase risk. Anorexia is different: it's polygenic, meaning many different genetic variants likely contribute to susceptibility. "The best way to think about what I do is, I look for the BRCA1 and BRCA2 of anorexia," he said.

The researchers are careful to note that their study involved a specialized group of patients with particularly difficult cases. The finding must be replicated in a larger, independent population before anyone knows how broadly it applies. But if PLIN4 proves significant, it opens a new direction entirely. Genes don't work in isolation—they're part of larger biological pathways. If researchers can map those pathways, they can hunt for drug targets. "Discovering genes that underlie this disease isn't going to fix the disease," Robison said. "But what it can do is teach us what's causing the disease in lots of people, and we can use that information to design new treatments." Next, the team will search for other genetic differences affecting fat storage and anorexia risk, and they'll examine patients' body fat itself for abnormalities that might reveal more about how the disease works. For now, the field has a new place to look—not in the brain, but in the body's most basic machinery for storing and using energy.

The idea of an anorexic gene not in the brain is completely novel.
— Michael Lutter, researcher and eating disorder clinician
The best way to think about what I do is, I look for the BRCA1 and BRCA2 of anorexia—variants that are rare but dramatically increase your risk.
— Michael Lutter
Möchten Sie die ganze Geschichte? Das Original lesen bei Medical Xpress ↗
Kontakt FAQ